TKM-080301

· Arbutus Biopharma Corporation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TKM-080301, covering 2019-01-16 to 2019-01-16. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients [Phase 1, Phase 2]

See pricing